Results 221 to 230 of about 35,727 (262)

Haemophilus influenzae global epidemiology and antimicrobial susceptibility patterns including ampicillin and amoxicillin-clavulanate resistance based on β-lactamase production, 2013-2022. [PDF]

BMC Infect Dis
Sfeir MM.
europepmc   +1 more source

AMRrounds: What goes around comes back around-recurrent KPC-producing <i>Salmonella</i> bacteraemia. [PDF]

JAC Antimicrob Resist
Marx AH, Dial CN, Footer B.
europepmc   +1 more source

Whole Genome Sequencing of Uropathogenic <i>E. Coli</i> from Ireland Reveals Diverse Resistance Mechanisms and Strong Correlation with Phenotypic (EUCAST) Susceptibility Testing

Shane Whelan, Francesca Bottacini, Colin Buttimer, Karen Finn, Brigid Lucey   +4 more
openalex   +1 more source

Machine learning for personalized antimicrobial susceptibility breakpoints. [PDF]

J Antimicrob Chemother
Zhong Y, Hope W, Buchan I, Velluva A, Gerada A, Rosato C, Green PL, Howard A.   +7 more
europepmc   +1 more source

Burkholderia pseudomallei in Sarawak, Malaysian Borneo, Remains Highly Susceptible to Trimethoprim-Sulfamethoxazole Despite Resistance to Its Individual Components. [PDF]

Pathogens
Sumbu LL, Sia TL, Ooi MH, Mohan A, Wong JS, Podin Y.   +5 more
europepmc   +1 more source

ブレイクポイントをめぐる変化　CLSI、EUCAST

ブレイクポイントをめぐる変化　CLSI、EUCAST
openaire  

EUCAST Technical Note on Voriconazole and Aspergillus spp. [PDF]

Clinical Microbiology and Infection, 2013
The European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for voriconazole against Aspergillus spp. This Technical Note is based on the EUCAST rationale document for voriconazole (available on the EUCAST website: http://www.eucast.org).
William Hope, Manuel Cuenca‐Estrella, Cornelia Lass‐Flörl, Maiken Cavling Arendrup   +3 more
exaly   +4 more sources

EUCAST Technical note on Amphotericin B [PDF]

Clinical Microbiology and Infection, 2011
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for amphotericin B for Candida spp. This Technical Note is based on the EUCAST amphotericin B rationale document (available on the EUCAST website: http://www.eucast.org).
Cornelia Lass-Flörl
exaly   +3 more sources